Choose Rich Live
Tech

Deepinder Goyal defends Temple wearable amid scrutiny from medical experts

Deepinder Goyal has pushed back against doctors questioning his wearable device Temple, characterizing it as a wellness tracker rather than a medical device and citing millions invested in its development.

Deepinder Goyal wearing the Temple device alongside a screenshot of his social media statement defending the product as a fitness wearable.
Image: @Inc42

Deepinder Goyal has mounted a defense of his wearable device, Temple, amid mounting scrutiny from medical experts demanding to know its scientific basis and questioning its ability to measure cerebral blood flow. Responding to the backlash, Goyal stated that Temple is a fitness and wellness wearable rather than a medical device, placing it outside the purview of doctors and meaning no clinical outcomes need to be validated.[2][5]

Critics have flagged a lack of peer-reviewed studies, and Goyal acknowledged that the wearable has not been clinically validated. However, he maintained that peer review is a process that will happen soon and that independent studies will emerge as Temple becomes more widely available. Goyal also told The Economic Times that most of the device's groundbreaking features have not yet been made public, and he noted that the company is additionally building Blinkit Ambulances.[2][3]

In defending the product's credibility, Goyal cited substantial financial backing, stating that $30 million had been spent on development, including $20 million of his own money. The Hindu also reported him pointing to a ₹282.55 crore investment in the device alongside his decision to step down as Eternal CEO. Priced at ₹85,000, Temple opened for pre-orders on November 1, with deliveries expected to begin in early 2027.[1][2][4]

Key facts

  • Medical experts and critics questioned Temple's scientific credibility, peer-reviewed research backing, and claims regarding measuring cerebral blood flow.
  • Goyal stated Temple is a fitness and wellness wearable rather than a medical device, arguing it is outside doctors' purview and requires no clinical outcome validation.
  • Goyal acknowledged Temple lacks clinical validation, but stated peer reviews will happen soon and independent studies will emerge over time.
  • Goyal stated that most of Temple's groundbreaking features are not yet public.
  • Goyal stated he spent $30 million developing Temple, including $20 million of his personal money, with The Hindu reporting he cited an investment of ₹282.55 crore and his stepping down as Eternal CEO.
  • Temple opened pre-orders on November 1 at ₹85,000, with shipments scheduled to start in early 2027.

Sources · 5 sources

  1. TH

    The Hindu@the_hinduPost on X ·

    Facing growing scrutiny over his wearable device ‘Temple’, Deepinder Goyal defended the product, citing his decision to step down as Eternal CEO and invest ₹282.55 crore in its development. https://t.co/hz5wxNZpOQ

    Open source
  2. IN

    Inc42@Inc42Post on X ·

    “Temple Is A Fitness Tracker, Not A Medical Device,” says Deepinder Goyal. 👀 Amid growing criticism over Temple’s scientific credibility and its ability to measure cerebral blood flow, the founder has defended the research behind the wearable. Goyal said Temple has spent $30 Mn on development, including $20 Mn of his personal money. He also maintained that the device has not been clinically validated and that the company expects independent studies to emerge as it becomes more widely available. Meanwhile, medical experts have questioned its claims, while critics have flagged the lack of peer-reviewed studies. Priced at ₹85,000, Temple opened pre-orders on November 1, with shipments expected to begin in early 2027. 🔗 To read the article in detail, click here: https://t.co/4X5CjYNMag #DeepinderGoyal #Temple #Wearables #HealthTech #News

    Open source
  3. ET

    Economic Times@EconomicTimesPost on X ·

    Deepinder Goyal defends Temple amid doctors' criticism: 'Most ground breaking features are not even public yet' https://t.co/TDx3D7Sd5s

    Open source
  4. BT

    Business Today@business_todayPost on X ·

    #TechToday | 'Spent $30 million, including $20 million of my own': Deepinder Goyal responds to doctors questioning Temple https://t.co/Hy0ATkyLNu

    Open source
  5. MI

    Mint@livemintPost on X ·

    Eternal founder Deepinder Goyal's wearable device Temple is navigating a social media storm, as doctors demand to know its scientific basis while Goyal defends his product as a fitness tracker and wellness product. https://t.co/NTgMyPh46z

    Open source